Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.46 USD | -4.62% | -7.10% | -5.64% |
24/05 | JOHNSON MATTHEY : Higher transformation costs take their toll | |
23/05 | JOHNSON MATTHEY : ICEs might stay longer |
Strengths
- The company's profit outlook over the next few years is a strong asset.
- With a P/E ratio at 10.9 for the current year and 8.9 for next year, earnings multiples are highly attractive compared with competitors.
- This company will be of major interest to investors in search of a high dividend stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Over the past four months, analysts' average price target has been revised upwards significantly.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-5.64% | 3.83B | - | ||
+20.59% | 68.31B | A- | ||
-1.17% | 48.49B | A- | ||
+32.00% | 28.29B | A- | ||
+7.49% | 19.12B | C+ | ||
+10.80% | 16.64B | B+ | ||
-5.73% | 16B | B+ | ||
-21.45% | 15.84B | A- | ||
-20.45% | 13.51B | C+ | ||
-24.56% | 12.98B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- JMAT Stock
- JMPLY Stock
- Ratings Johnson Matthey Plc